ATE354576T1 - Neues, aus kulturfermentierungen isoliertes sordarinderivat und wirkungen als antipilzmittel - Google Patents

Neues, aus kulturfermentierungen isoliertes sordarinderivat und wirkungen als antipilzmittel

Info

Publication number
ATE354576T1
ATE354576T1 AT02786991T AT02786991T ATE354576T1 AT E354576 T1 ATE354576 T1 AT E354576T1 AT 02786991 T AT02786991 T AT 02786991T AT 02786991 T AT02786991 T AT 02786991T AT E354576 T1 ATE354576 T1 AT E354576T1
Authority
AT
Austria
Prior art keywords
sordarine
effects
new
antifungal agent
derivative isolated
Prior art date
Application number
AT02786991T
Other languages
English (en)
Inventor
Ziqiang Guan
Guy H Harris
Michael C Justice
Jennifer Nielsen-Kahn
Mythili S Shastry
Angela Basilio
Javier Collado
Maria Teresa Diez
Original Assignee
Merck & Co Inc
Merck Sharp & Dohme De Espana
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc, Merck Sharp & Dohme De Espana filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE354576T1 publication Critical patent/ATE354576T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fertilizers (AREA)
AT02786991T 2001-12-14 2002-12-10 Neues, aus kulturfermentierungen isoliertes sordarinderivat und wirkungen als antipilzmittel ATE354576T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34036701P 2001-12-14 2001-12-14

Publications (1)

Publication Number Publication Date
ATE354576T1 true ATE354576T1 (de) 2007-03-15

Family

ID=23333054

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02786991T ATE354576T1 (de) 2001-12-14 2002-12-10 Neues, aus kulturfermentierungen isoliertes sordarinderivat und wirkungen als antipilzmittel

Country Status (8)

Country Link
US (1) US20040242904A1 (de)
EP (1) EP1458725B1 (de)
JP (1) JP2005519039A (de)
AT (1) ATE354576T1 (de)
AU (1) AU2002351340A1 (de)
CA (1) CA2469879A1 (de)
DE (1) DE60218341D1 (de)
WO (1) WO2003051889A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010074101A1 (ja) * 2008-12-25 2010-07-01 住友化学株式会社 アミノピリジン化合物及びその用途
KR102526812B1 (ko) * 2021-01-11 2023-04-27 고려대학교 산학협력단 모리니아펀진을 유효성분으로 포함하는 식물병 방제용 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3146899A1 (de) * 1981-11-26 1983-06-01 Boehringer Mannheim Gmbh, 6800 Mannheim Neue ketale von 3'''-dehydro-cardenolid-tridigitoxosiden, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3431195A1 (de) * 1984-08-24 1986-03-06 Troponwerke GmbH & Co KG, 5000 Köln Neue benzodiazepine, verfahren zu ihrer herstellung sowie ihre verwendung
PE49696A1 (es) * 1994-11-08 1996-12-05 Glaxo Wellcome Sa Compuesto carbociclico
EP0711783A1 (de) * 1994-11-08 1996-05-15 Glaxo, S.A. Antifungale Sordarinderivate
USRE38984E1 (en) * 1996-09-12 2006-02-14 Merck & Co., Inc. Antifungal combination therapy
US6436395B1 (en) * 1996-09-18 2002-08-20 Merck & Co., Inc. Rosellinia subiculata ATCC 74386 and fungus ATCC 74387 for producing sordarin compounds for fungi control
US6040463A (en) * 1996-10-07 2000-03-21 Merck & Co., Inc. Sordarin derivatives
US5972996A (en) * 1997-08-22 1999-10-26 Merck & Co., Inc. 4-cyano-4-deformylsordarin derivatives
US5965612A (en) * 1997-08-22 1999-10-12 Merck & Co., Inc. 4-cyano-4-deformylsordaricin derivatives
US6136853A (en) * 1997-10-03 2000-10-24 Merck & Co., Inc. Sordarin derivatives
ES2211191T3 (es) * 1998-10-26 2004-07-01 MERCK & CO., INC. Producto de transformacion microbiana.

Also Published As

Publication number Publication date
EP1458725A4 (de) 2005-09-07
CA2469879A1 (en) 2003-06-26
US20040242904A1 (en) 2004-12-02
EP1458725A1 (de) 2004-09-22
EP1458725B1 (de) 2007-02-21
DE60218341D1 (de) 2007-04-05
AU2002351340A1 (en) 2003-06-30
JP2005519039A (ja) 2005-06-30
WO2003051889A1 (en) 2003-06-26

Similar Documents

Publication Publication Date Title
ATE397385T1 (de) Biofungizide
TR200102809T2 (tr) Bitki hastalıklarının kontrol edilmesi için bacillus pumilus soyu
GB0223038D0 (en) Therapeutic compounds
RS52671B (en) IMPROVED TESTOSTERON GEL AND USE PROCEDURE
NZ734050A (en) Compositions comprising povidone-iodine
NO20065418L (no) Anvendelse av alkylkarboksylsyreamider som penetrasjonsfremmende midler
DE50312946D1 (de) Difluormethyl thiazolyl carboxanilide
RS53548B1 (en) THERAPEUTIC FORMULATIONS OF KERATINocyte GROWTH FACTORS
ITMI20041550A1 (it) Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide
TW200745339A (en) Antimicrobial active substrance DM0507 and the use thereof
RU2008139609A (ru) Способ пивоварения
WO2003097574A3 (en) Aminoalkoxy-functional chalcones
ATE354576T1 (de) Neues, aus kulturfermentierungen isoliertes sordarinderivat und wirkungen als antipilzmittel
DE60213802D1 (de) Cak inhibitoren und deren verwendungen
SG158899A1 (en) Peptidic compounds
ATE264059T1 (de) Bekämpfung von pilzbefall nach der ernte mittels saprophytischer hefe
WO2007082864A3 (en) Use of chavicol as an antiseptic
ATE260559T1 (de) Sordarinderivate
EP1222919A3 (de) Zusammensetzungen enthaltend Glykoproteinematrix und Wirkstoff und Verfahren zur Herstellung desselben
ATE255572T1 (de) Mikrobielle transformationsprodukte
DE60209355D1 (de) Kosmetische zubereitung gegen hautfalten
DE69813833T2 (de) 4-cyano-4-deformylsordarizin-derivate
DK1450616T3 (da) Præparation af krydderurter
DK1904511T3 (da) Homogemcitabin
ATE553184T1 (de) Hefe konditionierung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties